(HealthDay)—Pertactin-negative variants of Bordetella pertussis have been identified in the United States; and children who receive diphtheria-tetanus-whole-cell pertussis (DTwP) priming have lower reported rates of pertussis, ...
Feb 7, 2013
0
0
The study identifies the respective contributions of direct and indirect government support in research and development of new pharmaceutical drugs.
Dec 15, 2011
0
0
Researchers from Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have discovered a mechanism by which glioblastoma multiforme (GBM), the most common form of brain cancer, ...
Nov 3, 2011
0
0
(Medical Xpress)—Stanford University School of Medicine researchers have devised a two-part approach to identify developing human embryos most likely to result in successful pregnancies. The technique could transform the ...
Dec 5, 2012
0
0
Compounds in blueberries might turn out to have a powerful effect on formation of strong, healthy bones, if results from studies with laboratory rats turn out to hold true for humans.
Jun 21, 2011
0
0
When cells suffer too much DNA damage, they are usually forced to undergo programmed cell death, or apoptosis. However, cancer cells often ignore these signals, flourishing even after chemotherapy drugs have ravaged their ...
May 14, 2013
0
0
Nearly three-quarters (74%) of Georgia residents think spending money on research to improve health globally is important for economic development in Georgia, according to a new statewide poll commissioned by Research!America.
Jun 29, 2011
0
0
(Medical Xpress)—Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth ...
Oct 16, 2012
0
0
The United States' global share of biomedical research spending fell from 51 percent in 2007 to 45 percent in 2012, while Japan and China saw dramatic increases in research spending.
Jan 1, 2014
0
0
Cancer drug development is known to be too slow, costly and fraught with failure. Now the U.S. Food and Drug Administration is issuing recommendations for breast cancer trials that would substantially accelerate patient access ...
Jun 4, 2012
0
0
